Ladenburg Thalmann Appoints Christopher S. James, M.D. as Managing Director, Equity Research Covering Biotechnology
January 06 2017 - 8:00AM
Business Wire
Ladenburg Thalmann Financial Services Inc. (NYSE MKT: LTS, LTS
PrA), announced today that Christopher S. James, M.D. has been
appointed as Managing Director, Equity Research at Ladenburg
Thalmann & Co. Inc. ("Ladenburg") covering biotechnology. Dr.
James is based in Ladenburg’s New York office.
David Rosenberg, Co-President and Chief Executive Officer of
Ladenburg Thalmann & Co. Inc., said, “We are delighted to
welcome Chris to Ladenburg. Chris has differentiated himself in the
market with his experience covering a wide range of biotechnology
companies and unique background as a physician, specifically as a
neurosurgeon. We look forward to his insights and expertise as the
newest member of our biotechnology team.”
Dr. James joins Ladenburg with more than a decade of experience
as a biotechnology analyst focused on small, mid and large-cap
companies across multiple therapeutic areas. Most recently, he
served as Senior Biotechnology Equity Research Analyst at FBR
Capital Markets. Prior to joining FBR, Dr. James held Senior
Analyst roles at Brinson Patrick Securities, MLV & Co. and
Rodman & Renshaw. Dr. James also previously served as the first
Chief Medical Officer of Retrophin Inc., a public biotechnology
company focused on developing orphan drug therapies to treat rare
diseases, and managed business development at Daiichi Sankyo,
Inc.
Dr. James received a Medical Degree from the Yale University
School of Medicine and a Bachelor of Science in Biology from
Cornell University. He is a licensed physician with training in
general surgery, neurology and neurosurgery from Weill-Cornell New
York Hospital and Memorial Sloan Kettering Cancer Center.
About Ladenburg
Ladenburg Thalmann Financial Services Inc. (NYSE MKT: LTS, LTS
PrA) is a publicly-traded diversified financial services company
based in Miami, Florida. Ladenburg’s subsidiaries include
industry-leading independent broker-dealer firms Securities
America, Inc., Triad Advisors, Inc., Securities Service Network,
Inc., Investacorp, Inc. and KMS Financial Services, Inc., as well
as Premier Trust, Inc., Ladenburg Thalmann Asset Management Inc.,
Highland Capital Brokerage, Inc., a leading independent life
insurance brokerage company, and Ladenburg Thalmann & Co. Inc.,
an investment bank which has been a member of the New York Stock
Exchange for over 135 years. The company is committed to investing
in the growth of its subsidiaries while respecting and maintaining
their individual business identities, cultures, and leadership. For
more information, please visit www.ladenburg.com.
View source
version on businesswire.com: http://www.businesswire.com/news/home/20170106005100/en/
Sard Verbinnen & CoPaul Caminiti/Emily Deissler/Benjamin
Spicehandler212-687-8080
Ladenburg Thalmann Finan... (AMEX:LTS)
Historical Stock Chart
From Mar 2024 to Apr 2024
Ladenburg Thalmann Finan... (AMEX:LTS)
Historical Stock Chart
From Apr 2023 to Apr 2024